These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29206062)
1. Discrimination between primary low-grade and high-grade glioma with Falk Delgado A; Falk Delgado A Br J Radiol; 2018 Feb; 91(1082):20170426. PubMed ID: 29206062 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
3. Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy. Falk Delgado A; Nilsson M; van Westen D; Falk Delgado A Radiology; 2018 Apr; 287(1):119-127. PubMed ID: 29206593 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275 [TBL] [Abstract][Full Text] [Related]
6. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of MR diffusion kurtosis imaging for differentiating low-grade from high-grade glioma before surgery: A systematic review and meta-analysis. Xu C; Li C; Xing C; Li J; Jiang X Clin Neurol Neurosurg; 2022 Sep; 220():107373. PubMed ID: 35878557 [TBL] [Abstract][Full Text] [Related]
8. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis. Muoio B; Albano D; Dondi F; Bertagna F; Garibotto V; Kunikowska J; Piccardo A; Annunziata S; Espeli V; Migliorini D; Treglia G Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885569 [TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of Positron Emission Tomography in Patients with Malignant Glioma. Yano H; Shinoda J; Iwama T Neurol Med Chir (Tokyo); 2017 Jul; 57(7):312-320. PubMed ID: 28458384 [TBL] [Abstract][Full Text] [Related]
11. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET. Malkowski B; Harat M; Zyromska A; Wisniewski T; Harat A; Lopatto R; Furtak J PLoS One; 2015; 10(10):e0140917. PubMed ID: 26468649 [TBL] [Abstract][Full Text] [Related]
13. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis. de Zwart PL; van Dijken BRJ; Holtman GA; Stormezand GN; Dierckx RAJO; Jan van Laar P; van der Hoorn A J Nucl Med; 2020 Apr; 61(4):498-504. PubMed ID: 31541032 [TBL] [Abstract][Full Text] [Related]
15. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. Albert NL; Winkelmann I; Suchorska B; Wenter V; Schmid-Tannwald C; Mille E; Todica A; Brendel M; Tonn JC; Bartenstein P; la Fougère C Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1105-14. PubMed ID: 26666239 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine? Moulin-Romsée G; D'Hondt E; de Groot T; Goffin J; Sciot R; Mortelmans L; Menten J; Bormans G; Van Laere K Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2082-7. PubMed ID: 17763978 [TBL] [Abstract][Full Text] [Related]
17. MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Jansen NL; Graute V; Armbruster L; Suchorska B; Lutz J; Eigenbrod S; Cumming P; Bartenstein P; Tonn JC; Kreth FW; la Fougère C Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1021-9. PubMed ID: 22491781 [TBL] [Abstract][Full Text] [Related]
18. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging. Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372 [TBL] [Abstract][Full Text] [Related]